Snap-on CEO Pinchuk sells 23,447 shares after exercise
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Snap-on Inc. (SNA) Chairman, President and CEO Nicholas T. Pinchuk exercised 33,750 stock options at an exercise price of $168.70 per share on November 11, 2026, acquiring 33,750 common shares. He sold 23,447 shares in five reported transactions, at weighted-average prices ranging from $370.9616 to $374.5806 per share. The exercise and sales were pursuant to a Rule 10b5-1 plan adopted on November 3, 2025. A portion of the underlying shares was sold to cover the exercise price and estimated tax liability.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F10, F9 | 33,750 | -- | -- |
| Exercise | Common Stock F1, F2 | 33,750 | $168.70 | $5.69M |
| Sale | Common Stock F1, F3 | 932 | $370.9616 | $346K |
| Sale | Common Stock F1, F4 | 4,108 | $371.7053 | $1.53M |
| Sale | Common Stock F1, F5 | 3,164 | $372.7402 | $1.18M |
| Sale | Common Stock F1, F6 | 5,419 | $373.668 | $2.02M |
| Sale | Common Stock F1, F7 | 9,824 | $374.5806 | $3.68M |
| Holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| Holding | Restricted Stock Units F12, F13 | -- | -- | -- |
| Holding | Restricted Stock Units F12, F13 | -- | -- | -- |
| Holding | Restricted Stock Units F12, F13 | -- | -- | -- |
| Holding | Performance Units F12, F14 | -- | -- | -- |
| Holding | Performance Units F12, F15 | -- | -- | -- |
| Holding | Performance Units F12, F16 | -- | -- | -- |
| Holding | Deferred Stock Units F12, F17, F8 | -- | -- | -- |
| Holding | Common Stock F8 | -- | -- | -- |
Footnotes (17)
- F1. The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
- F2. Includes 0.0062 shares acquired under a dividend reinvestment plan.
- F3. This transaction was executed in multiple trades at prices ranging from $370.20 to $371.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F4. This transaction was executed in multiple trades at prices ranging from $371.20 to $372.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F5. This transaction was executed in multiple trades at prices ranging from $372.20 to $373.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F6. This transaction was executed in multiple trades at prices ranging from $373.20 to $374.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F7. This transaction was executed in multiple trades at prices ranging from $374.20 to $375.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F8. This information is based on a plan statement dated September 30, 2026.
- F9. Option fully vested.
- F10. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
- F11. Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
- F12. 1 for 1.
- F13. The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
- F14. If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F15. If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F16. If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F17. Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
Key Figures
Key Terms
Rule 10b5-1 Plan regulatory
Rule 16b-3 stock option regulatory
weighted average sale price financial
Restricted Stock Units financial
Performance Units financial
Deferred Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many SNA options did Nicholas T. Pinchuk exercise, and at what price?
AI-generated analysis. How Rhea-AI works. Not financial advice.